Tech Company Financing Transactions
Synklino Funding Round
On 6/8/2022, Synklino raised $31.4 million in Series A investment from Eir Ventures.
Transaction Overview
Company Name
Announced On
6/8/2022
Transaction Type
Venture Equity
Amount
$31,400,000
Round
Series A
Investors
Proceeds Purpose
New financing will advance clinical trials with Synklino's drug candidate SYN002 for the treatment of cytomegalovirus (CMV)
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Rådhusvej 13
Charlottenlund, 2920
Denmark
Charlottenlund, 2920
Denmark
Phone
Website
Email Address
Overview
Synklino is a Danish biotech company developing groundbreaking therapies against chronic viral infections. The company is owned by renowned Nordic funds and institutional investors Eir Ventures, The Danish Growth Fund and PKA as well as approximately 70 private shareholders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Kledal
Chief Financial Officer
Carit Andersen
Chief Marketing Officer
Josefin-Beate Holz
Chief Operating Officer
Jette Sen
Browse more venture capital transactions:
Prev: 6/8/2022: NymCard venture capital transaction
Next: 6/8/2022: 443ID venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs